Results you can trust

Our team of hematopathologists provides academic-caliber, definitive diagnoses. Inform Diagnostics believes in responsible assay utilization and only orders those tests that are clinically appropriate for accurate diagnosis, giving patients peace of mind, and helping clinicians build sustainable practices.

Test Offerings

Timely, definitive diagnoses for hematology/oncology

Below is a sampling of tests offered by InformDx. For full test details and indications, please contact us.


  • Bone marrow morphologic evaluation
  • Peripheral blood morphologic evaluation
  • Tissue morphologic evaluation/consultation (such as lymph node or slides prepared elsewhere)


  • Immunohistochemistry (IHC) for hundreds of markers

Flow Cytometry

  • Leukemia/Lymphoma panel
  • Paroxysmal nocturnal hemoglobinuria (PNH)

Cytogenetic Analysis

  • Cytogenetic Analysis
  • Cytogenetic Analysis with reflex to FISH if clinically indicated

Fluorescence in situ hybridization (FISH)

  • B-cell acute lymphoblastic leukemia panel
  • T-cell acute lymphoblastic leukemia panel
  • Acute myeloid leukemia panel
  • Acute promyelocytic leukemia panel
  • B-cell chronic lymphocytic leukemia panel
  • Chronic myeloid leukemia
  • Eosinophilia panel
  • Myelodysplastic syndrome panel
  • Myeloproliferative neoplasm panel
  • Plasma cell neoplasm panel
  • B-cell non-Hodgkin lymphoma panel
  • DLBCL-double, triple hit panel
  • CD5(-)/CD10(-) lymphoproliferative panel
  • Marginal zone/MALT1 panel
  • Follicular lymphoma
  • Burkitt lymphoma
  • Mantle cell lymphoma
  • Anaplastic large cell lymphoma panel
  • Malignant melanoma panel
  • HER2
  • ROS1
  • MET
  • RET
  • UroVysion®

Molecular Testing

  • Heme NGS Profile (Includes DNA and RNA Sequencing) See Heme NGS Profile Gene List here
  • Acute myeloid leukemia prognostic profile
  • FLT-3
  • NPM1
  • KIT exons 8 & 17
  • IDH1/IDH2
  • PML/RARA (quantitative)
  • BCR-ABL major p210/minor p190 (quantitative)
  • BCR/ABL kinase domain point mutation (T315I)
  • Myeloproliferative neoplasm panel
  • JAK2 V617F (qualitative)
  • JAK2 exon
  • MPL
  • Calreticulin (CALR)
  • KIT (D816V) — sensitivity: 0.1%
  • B-cell clonality (gene rearrangement testing)
  • T-cell clonality (gene rearrangement testing)
  • IgVH mutation analysis for CLL/SLL
  • MYD88 L265P and CXCR4
  • BCL-1/CCND1 (qualitative)
  • BRAF V600E for hairy cell leukemia